Rapamycin has emerged as a leading compound in longevity research, with decades of evidence showing it targets key aging pathways. But experts say important questions about long-term safety, dosing, and benefits for healthy people remain unanswered.
Rapamycin: Where Science Ends and the Promises Begin
by | Jul 23, 2026 | Uncategorized | 0 comments

Recent Comments